claim: significantly decreased mortality in a large cohort of coronavirus disease 2019 patients transfused early with convalescent plasma containing high-titer antisevere acute respiratory syndrome coronavirus 2 spike protein igg
evidence_1: treatment of coronavirus disease 2019 patients with convalescent plasma reveals a signal of significantly decreased mortality.